Anna Piskorz
Papers
1
Total Citations
109
H-Index
1
About
Dr. Anna Piskorz is a leading translational cancer researcher whose work has fundamentally advanced the field of liquid biopsy. Her primary research focuses on circulating tumor DNA (ctDNA) and the pre-analytical variables that govern its reliable detection in plasma. Her most cited work, a 2018 study with 109 citations, systematically characterized how collection and processing procedures impact cell-free DNA (cfDNA) levels from leukocyte lysis. This critical contribution established standardized protocols that are now essential for ensuring the accuracy and reproducibility of ctDNA assays in clinical settings. By solving these foundational technical challenges, Dr. Piskorz has enabled more robust noninvasive cancer detection and monitoring. Her research directly addresses the difficulty of isolating the minor ctDNA fraction from total cfDNA, paving the way for more sensitive liquid biopsies. Through her meticulous work, she has become a key figure in making noninvasive cancer management a practical reality, with her findings widely adopted by laboratories and clinical trials worldwide.
Research Focus
Key Achievements
Top Papers
- 1